Hodgkin's and non-Hodgkin's lymphoma

Por Leonard, John P., Coleman, Morton.
Publicado em 2006

Radioimmunotherapy with tositumomab and iodine-131 tositumomab for non-Hodgkin’s lymphoma

Por Andemariam, Biree, Leonard, John P
Publicado em 2007

Targeting angiogenesis: A novel, rational therapeutic approach for Non-Hodgkin’s Lymphoma

Por Ruan, Jia, Leonard, John P.
Publicado em 2009

Phosphorylation-State-Dependent Regulation of NMDA Receptor Short-Term Plasticity Modifies Hippocampal Dendritic Ca(2+) Transients

Por Chatterjea, Debika, Hamid, Edaeni, Leonard, John P., Alford, Simon
Publicado em 2010

Pilot Study of Aurora, a Social, Mobile-Phone-Based Emotion Sharing and Recording System

Por Gay, Geri, Pollak, JP, Adams, Phil, Leonard, John P
Publicado em 2011

Therapeutic implication of concomitant chromosomal aberrations in patients with aggressive B-cell lymphomas

Por Marullo, Rossella, Rutherford, Sarah C., Leonard, John P., Cerchietti, Leandro
Publicado no Cell Cycle (2016)

Myelin/Axonal Pathology in Interleukin-12 Induced Serial Relapses of Experimental Allergic Encephalomyelitis in the Lewis Rat

Por Ahmed, Zubair, Gveric, Djordje, Pryce, Gareth, Baker, David, Leonard, John P., Cuzner, M. Louise
Publicado em 2001

Behavioral and Physiological Characterization of PKC-dependent Phosphorylation in the Grin2aΔPKC mouse

Por Balu, Deebika, Larson, John R., Schmidt, Jennifer V., Wirtshafter, David, Yevtodiyenko, Aleksey, Leonard, John P.
Publicado no Brain Res (2016)

Expression and Regulation of the PD-L1 Immunoinhibitory Molecule on Microvascular Endothelial Cells

Por EPPIHIMER, MICHAEL J., GUNN, JASON, FREEMAN, GORDON J., GREENFIELD, EDWARD A., CHERNOVA, TETYANA, ERICKSON, JAMIE, LEONARD, JOHN P.
Publicado em 2002

A Role for Caspase-1 and -3 in the Pathology of Experimental Allergic Encephalomyelitis : Inflammation Versus Degeneration

Por Ahmed, Zubair, Doward, Anne I., Pryce, Gareth, Taylor, Deanna L., Pocock, Jennifer M., Leonard, John P., Baker, David, Cuzner, M. Louise
Publicado em 2002

Phase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomas

Por Martin, Peter, Furman, Richard R., Rutherford, Sarah, Ruan, Jia, Ely, Scott, Greenberg, June, Coleman, Morton, Goldsmith, Stanley J., Leonard, John P.
Publicado no Leuk Lymphoma (2015)

Durable Responses with the Metronomic Regimen RT-PEPC in Elderly Patients with Recurrent Mantle Cell Lymphoma

Por Ruan, Jia, Martin, Peter, Coleman, Morton, Furman, Richard R., Cheung, Ken, Faye, Adam, Elstrom, Rebecca, Lachs, Mark, Hajjar, Katherine A., Leonard, John P.
Publicado em 2010

Induction of prolonged early G(1) arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1

Por Chiron, David, Martin, Peter, Di Liberto, Maurizio, Huang, Xiangao, Ely, Scott, Lannutti, Brian J., Leonard, John P., Mason, Christopher E., Chen-Kiang, Selina
Publicado em 2013

Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes

Por Ruan, Jia, Luo, Min, Wang, Chunjie, Fan, Lei, Yang, Shao Ning, Cardenas, Mariano, Geng, Huimin, Leonard, John P., Melnick, Ari, Cerchietti, Leandro, Hajjar, Katherine A.
Publicado em 2013

Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance)

Por Leonard, John P., Jung, Sin-Ho, Johnson, Jeffrey, Pitcher, Brandelyn N., Bartlett, Nancy L., Blum, Kristie A., Czuczman, Myron, Giguere, Jeffrey K., Cheson, Bruce D.
Publicado no J Clin Oncol (2015)

A phase II trial of extended induction epratuzumab and rituximab for previously untreated follicular lymphoma: CALGB 50701

Por Grant, Barbara W., Jung, Sin-Ho, Johnson, Jeffrey L., Kostakoglu, Lale, His, Eric, Byrd, John C., Jones, Jeffrey, Leonard, John P., Martin, S. Eric, Cheson, Bruce D.
Publicado em 2013

Efficacy of Enzyme and Substrate Reduction Therapy with a Novel Antagonist of Glucosylceramide Synthase for Fabry Disease

Por Ashe, Karen M, Budman, Eva, Bangari, Dinesh S, Siegel, Craig S, Nietupski, Jennifer B, Wang, Bing, Desnick, Robert J, Scheule, Ronald K, Leonard, John P, Cheng, Seng H, Marshall, John
Publicado no Mol Med (2015)

Pharmacoproteomics identifies combinatorial therapy targets for diffuse large B cell lymphoma

Por Goldstein, Rebecca L., Yang, Shao Ning, Taldone, Tony, Chang, Betty, Gerecitano, John, Elenitoba-Johnson, Kojo, Shaknovich, Rita, Tam, Wayne, Leonard, John P., Chiosis, Gabriela, Cerchietti, Leandro, Melnick, Ari
Publicado no J Clin Invest (2015)

CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease

Por Marshall, John, Sun, Ying, Bangari, Dinesh S, Budman, Eva, Park, Hyejung, Nietupski, Jennifer B, Allaire, Amy, Cromwell, Mary A, Wang, Bing, Grabowski, Gregory A, Leonard, John P, Cheng, Seng H
Publicado no Mol Ther (2016)

Bendamustine Is Effective Therapy in Patients With Rituximab-Refractory, Indolent B-cell Non-Hodgkin Lymphoma: Results From a Multicenter Study

Por Kahl, Brad S., Bartlett, Nancy L., Leonard, John P., Chen, Ling, Ganjoo, Kristen, Williams, Michael E., Czuczman, Myron S., Robinson, K. Sue, Joyce, Robin, van der Jagt, Richard H., Cheson, Bruce D.
Publicado em 2010